Back to Authors

Lama, Janette Contreras‐De

A5037874386 | I2948539688

Mayo Clinic

AbbVie (United States)

Citations 4

Characterizing Within Participant Consistency of Prodromal Symptoms in Migraine: Results from the PRODROME Trial Screening Period (P8-12.001)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208887

Gaps in Acute Treatment Optimization in Participants with Migraine: Results from the US Cohort of the Chronic Migraine Epidemiology and Outcomes—International (CaMEO-I) Study (S22.003)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206278

Within-Person Analysis of Ubrogepant Treatment of Mild Versus Moderate-Severe Headache Pain during a Phase 3 Long-Term Safety Extension Trial (S31.006)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.167

Characterizing Pre-headache (Prodrome) Features of Migraine Attacks: Results From the CaMEO Study (S4.004)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.1208